Blog Source: mim.globalhealthstrategies.com
Kenya's Vice-President Kalonzo Musyoka opened the conference. The first MIM conference to be held in four years, it will highlight the latest research in malaria prevention and treatment. “The theme of this year's conference is ...
Blog Source: africanpress.wordpress.com
“The Phase III trial is the outcome of a 9-year collaboration between the Path Malaria Vaccine Initiative and GSK Biological, now in partnership with a network of outstanding study centres in Africa, such as the three here in Kenya,” ...
Blog Source: www.seattlepi.com
"As scientists we have great hope that it will reduce the burden of malaria," he said. Joe Cohen, a top researcher for GlaxoSmithKline, said all the data collected during testing have been encouraging. The 66-year-old Cohen, ...
Blog Source: abantu.blogspot.com
Fast Forward to Kenya: That these same pharmaceutical companies, that are said to have partnered in formulating this vaccine, and who have provided Africa with umpteen malaria vaccines, could basically allow the Kenyan vaccine to be ...